Format

Send to

Choose Destination
Lancet. 2018 Jan 13;391(10116):122-123. doi: 10.1016/S0140-6736(18)30016-3.

GRECCAR2 trial: details worthy of more attention - Authors' reply.

Author information

1
Departments of Colorectal Surgery, Haut-Lévèque Hospital, CHU Bordeaux, Université de Bordeaux, Pessac 33600, France. Electronic address: eric.rullier@chu-bordeaux.fr.
2
Radiotherapy, Haut-Lévèque Hospital, CHU Bordeaux, Université de Bordeaux, Pessac 33600, France.
3
Departments of Colorectal Surgery, Haut-Lévèque Hospital, CHU Bordeaux, Université de Bordeaux, Pessac 33600, France.
4
Unité de Soutien Méthodologique à la Recherche Clinique et Epidémiologique du CHU de Bordeaux, Université Bordeaux, Bordeaux, France.
PMID:
29353619
DOI:
10.1016/S0140-6736(18)30016-3
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center